Track Real Time Price

According to ChemAnalyst, The global Metronidazole Prices experienced mixed regional movements during the second quarter of 2026, reflecting differences in raw material costs, manufacturing expenses, and pharmaceutical demand. In North America, prices increased amid higher production costs and inflationary pressures. The Asia-Pacific (APAC) market also recorded a quarterly price increase, particularly in China, where rising raw material expenses influenced market assessments. In contrast, the European market experienced a decline in prices, with weaker regional demand offsetting the impact of higher production costs. Metronidazole is an antimicrobial pharmaceutical ingredient widely used in medicines for treating infections caused by susceptible anaerobic bacteria and certain parasites. Its importance in the pharmaceutical supply chain makes its pricing closely linked to active pharmaceutical ingredient (API) manufacturing costs, raw material availability, energy expenses, regulatory ...

According to ChemAnalyst, The global Methyldopa prices recorded an upward trend during the second quarter of 2026, as rising production costs, raw material price pressure, and sustained pharmaceutical demand influenced pricing across major regions. Markets in Asia-Pacific (APAC), North America, and Europe experienced varying degrees of price increases, reflecting differences in manufacturing expenses, energy costs, trade conditions, and regional healthcare demand. Methyldopa, an antihypertensive pharmaceutical ingredient used to manage high blood pressure, remains relevant to healthcare supply chains, particularly for specific patient populations requiring established blood pressure management therapies. Its pricing is influenced by the availability of pharmaceutical-grade raw materials, manufacturing efficiency, quality-control requirements, regulatory compliance, and procurement conditions. During Q2 2026, higher producer prices contributed to increased manufacturing expenses in Chi...